U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2017
411
Name Type Language
INOTUZUMAB OZOGAMICIN
INN   MART.   USAN   WHO-DD  
USAN   INN  
Official Name English
BESPONSA
Preferred Name English
WAY-207294
Code English
INOTUZUMAB OZOGAMICIN [MART.]
Common Name English
Inotuzumab ozogamicin [WHO-DD]
Common Name English
CMC-544
Code English
IMMUNOGLOBULIN G4 (ANTI-(HUMAN CD22 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL G544 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL G544 .KAPPA.-CHAIN, DIMER, METHYL ((1R,4Z,8S,13E)-8-((2-O-(4-(ACETYLETHYLAMINO)-2,4-DIDEOXY-3-O-METHYL-.ALPHA.-L-THREO-PENTOPY
Common Name English
INOTUZUMAB OZOGAMICIN [MI]
Common Name English
INOTUZUMAB OZOGAMICIN [JAN]
Common Name English
INOTUZUMAB OZOGAMICIN [USAN]
Common Name English
PF-05208773
Code English
inotuzumab ozogamicin [INN]
Common Name English
INOTUZUMAB OZOGAMICIN [PURPLE BOOK CDER]
Common Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/13/1127
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
NDF-RT N0000193617
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
NCI_THESAURUS C155713
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
WHO-ATC L01XC26
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
FDA ORPHAN DRUG 391413
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
Code System Code Type Description
DRUG CENTRAL
5247
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
INN
8574
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
DAILYMED
P93RUU11P7
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
MESH
C480122
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
MERCK INDEX
m12031
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
NCI_THESAURUS
C71542
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
USAN
QQ-54
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
RXCUI
1942950
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
WIKIPEDIA
INOTUZUMAB OZOGAMICIN
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
EVMPD
SUB33081
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
FDA UNII
P93RUU11P7
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
CAS
635715-01-4
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
LACTMED
Inotuzumab Ozogamicin
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
ChEMBL
CHEMBL2108611
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
SMS_ID
100000125897
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
DRUG BANK
DB05889
Created by admin on Mon Mar 31 20:36:15 GMT 2025 , Edited by admin on Mon Mar 31 20:36:15 GMT 2025
PRIMARY
METABOLITE (PARENT)
INOTUZUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966